Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age in the United States

Journal of Women's Health

Volumn 22, Issue 7, 2013, Pages 595-603

  Yu, Jingbo ^a   Hu, X Henry ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BIRTH CONTROL; BREAST CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTRACEPTIVE BEHAVIOR; ETHNICITY; FEMALE; HEALTH HAZARD; HUMAN; HYPERTENSION; INTERNET; LIVER TUMOR; MAJOR CLINICAL STUDY; MEDICAID; MIGRAINE; PILL; PRIORITY JOURNAL; UNITED STATES; VAGINA RING; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; CONTRACEPTIVE DEVICES, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; INTERNET; MEDICATION ADHERENCE; PRESCRIPTION DRUG MISUSE; REPRODUCTIVE HEALTH; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84880105436     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3955     Document Type: Article

References (22)

1. U.S. Department of Health and Human Services. Healthy People 2020 Topics and Objectives. Available at: www .healthypeople.gov/topicsobjectives2020 Accessed May 3, 2012.
2. Finer LB, Zolna MR. Unintended pregnancy in the United States: Incidence and disparities, 2006. Contraception 2011; 84: 478-485.
3. United States Census Bureau. Population estimates: Historical data. Table 2: Annual estimates of the resident population by sex and selected age groups for the United States, April 1, 2000 to July 1, 2008. Available at: www.census.gov/ popest/data/historical/2000s/vintage-2008/index.html Accessed May 30, 2012.
4. Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. National Center for Health Statistics Reports, No. 60. Hyattsville, MD: National Center for Health Statistics. 2012.
5. Inman W, Vessey M, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J 1970;2: 203-209.
6. Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009;53: 221-231.
7. Burkman R, Bell C, Serfaty D. The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception 2011;84: 19-34.
8. Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Morb Mortal Wkly Rep 2010;59: 1-85.
9. Centers for Disease Control and Prevention. Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: Revised recommendations for the use of contraceptive methods during the postpartum period. MMWR Morb Mortal Wkly Rep 2011;60: 878-883.
10. Centers for Disease Control and Prevention. Update to CDC's U.S. Medical eligibility criteria for contraceptive use, 2010: Revised recommendations for the use of hormonal contraception among women at high risk for HIV or infected with HIV. MMWR Morb Mortal Wkly Rep 2012;61;449-452.
11. Curtis K, Tepper N, Marchbanks P. Putting risk into perspective: The U.S. medical eligibility criteria for contraceptive use. Rev Endocr Metab Disord 2011;12: 119-125.
12. Policar M. Contraception in women with chronic medical conditions. 5-30-2007. Available at: www.familypact.org/ Files/ Chronic%20Medical%20Conditions%20Webcast/PRW- ChronMedWebexSlideHandout20090317. pdf Accessed May 3, 2012.
13. Policar M. Using the 2010 U.S. medical eligibility criteria (US-MEC) for contraceptive use. 5-12-2011. Available at: www.familypact.org/Files/US-MEC-for- Contraceptive-Use- Webcast/2011-0512-SIT-USMECWebcastSlidehandouts-5- 11-11.pdf Accessed May 3, 2012.
14. Thorneycroft I, Klein P, Simon J. The impact of antiepileptic drug therapy on steroidal contraceptive efficacy. Epilepsy Behav 2006;9: 31-39.
15. National Center for Health Statistics. Summary health statistics for U.S. adults: National health interview survey, 2009. Vital and Health Statistics 2010;10: 1-207.
16. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology 1996;47: 52-59.
17. Kaiser Commission on Medicaid and the Uninsured. Ensuring access to care in Medicaid under health reform. Washington D.C.: The Henry J. Kaiser Family Foundation, 2011 (publication 8187).
18. Heinemann LAJ, Dinger JC. Range of published estimates of venous thromboembolism incidence in young women. Contraception 2007;75: 328-336.
19. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population- based study. Ann Intern Med 2005;143: 697-706.
20. Pomp ER, Lenselink AM, Rosendall FR, Doggen CJM. Pregnancy, the postpartum period and prothrombotic defects: Risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008;6: 632-637.
21. Salonen Ros H, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology 2001;12: 456-460.
22. Dinger JC, Heinemann LAJ, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: Final results from the European active surveillance study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007;75: 344-354.